Hardik Mody Selected Research

Hardik Mody Research Topics

4	Neoplasms (Cancer) 01/2021 - 04/2015
1	Cardiotoxicity 01/2021
1	Multiple Myeloma 01/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2021
1	Triple Negative Breast Neoplasms 01/2019
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Carcinoma (Carcinomatosis) 04/2015
1	Ovarian Neoplasms (Ovarian Cancer) 04/2015
1	Teratocarcinoma 04/2015
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2013

2	NucleosidesIBA 04/2015 - 01/2013
2	Pharmaceutical PreparationsIBA 04/2015 - 01/2013
2	Gemcitabine FDA Link 04/2015 - 01/2013
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021
1	idecabtagene vicleucelIBA 01/2021
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2021
1	Chimeric Antigen ReceptorsIBA 01/2021
1	Dacarbazine (DIC)FDA LinkGeneric 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	B-Cell Maturation AntigenIBA 01/2021
1	Chloroquine (Aralen)FDA LinkGeneric 01/2019
1	osimertinibIBA 01/2019
1	Epidermal Growth Factor (EGF)IBA 01/2019
1	Estrogen ReceptorsIBA 01/2019
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2019
1	PlatinumIBA 04/2015
1	Nucleoside Transport Proteins (Nucleoside Transporter)IBA 04/2015
1	Histones (Histone)IBA 01/2013
1	3-deazaneplanocinIBA 01/2013

2	Therapeutics 01/2021 - 01/2013